Company Filing History:
2 out of 42 
1 out of 1 Years Active: 2012-2014
Title: Luc Douay: Innovator in Hematopoietic Stem Cell Research
Introduction
Luc Douay is a prominent inventor based in Paris, France. He has made significant contributions to the field of hematopoietic stem cell research, particularly in the development of methods for producing red blood cells and enhancing blood flow to ischemic tissues. With a total of 2 patents, Douay's work has the potential to impact medical treatments for various conditions.
Latest Patents
Douay's latest patents include innovative methods for expanding CD133+ cells and producing red blood cells. The first patent, titled "Erythrocytes differentiated in vitro from nanofiber expanded CD133+ cells," provides methods and systems for expanding CD133+ cells. This invention aims to increase blood flow to ischemic tissues, such as the myocardium, and offers methods for directing the differentiation of these expanded cells. The second patent, "Method for producing red blood cells," outlines a two-step process for the expansion and differentiation of hematopoietic stem cells into enucleated erythrocytes. This method involves a culture medium that induces cell proliferation and erythroid differentiation in the presence of growth factors, followed by a reconstitution of the microenvironment without erythropoietin (EPO).
Career Highlights
Throughout his career, Luc Douay has worked with esteemed institutions, including Université Pierre et Marie Curie (Paris VI) and Arteriocyte Inc. His research has focused on advancing the understanding and application of stem cell technology in regenerative medicine.
Collaborations
Douay has collaborated with notable colleagues, including Marie-Catherine Giarratana and Ramasamy Sakthivel. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field.
Conclusion
Luc Douay's contributions to hematopoietic stem cell research and his innovative patents position him as a key figure in the medical field. His work continues to pave the way for advancements in treatments for ischemic conditions and blood-related disorders.